Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 801–900 of 1,000
Flaherty, D. C., Jalas, J. R., Sim, M., Stojadinovic, A., Protić, M., Lee, D. J., & Bilchik, A. J. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6405-x · Cited by 7
“In vitro analyses have demonstrated transient increases in FOXP3 T cells are linked to the increased activity of CD4 T cells.(33) Decreased clearance of tumor cells has”
BackgroundIkegawa, S., Meguri, Y., Mizuhara, K., Fukumi, T., Kobayashi, H., Sumii, Y., Kondo, T., Sando, Y., Iwamoto, M., Asada, N., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01167-8 · Cited by 7
Zhou, S., He, X., Mao, F., & Chu, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115529 · Cited by 6
Kwok, T., Hui, R. W., Mao, X., Ling, G., Wong, D. K.-H., Huang, F., Fung, J., Seto, W., Yuen, M., & Mak, L. (2024) · Journal of Viral Hepatitis · doi:10.1111/jvh.14007 · Cited by 8
“It is well known that peptide stimulation on PBMCs will cause phenotypic changes and thus will hinder accurate Tregs identification [27, 28].”
Bi, Y., Kong, R., Peng, Y., Yu, H., & Zhou, Z. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109716 · Cited by 7
Lee, J., Park, N., Nicosia, M., Park, J. Y., Pruett, S. B., & Seo, K. S. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300019 · Cited by 6
Kandulski, A., Wex, T., Kuester, D., Mönkemüller, K. E., Peitz, U., Roessner, A., & Malfertheiner, P. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0746-z · Cited by 6
“Also, other activated (non-regulatory) T cells were recently described to express FOXP3 as well [23, 24].”
BackgroundModulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive
Noel, G. L., Brinster, C., Sémana, G., & Bruniquel, D. (2009) · International Immunology · doi:10.1093/intimm/dxp068 · Cited by 6
Song, L., Ma, A., Dun, H., Hu, Y., Fujii, Y., Kinugasa, F., Oshima, S., Higashi, Y., Daloze, P., & Chen, H. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14039 · Cited by 7
“FoxP3 has been reported to be transiently expressed by activated nonregulatory T cells (17).”
BackgroundÉliás, S., Schmidt, A., Kannan, V., Andersson, J., & Tegner, J. N. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00603 · Cited by 6
“Based on these results, it is tempting to speculate that GM-CSF+FOXP3+ cells might be a subset of Treglike cells, or alternatively they might reflect activation-induced FOXP3 expression in human cells (51, 52).”
ResultHuman small intestine contains 2 functionally distinct regulatory T-cell subsets
Chauhan, S. K., Bartolomé-Casado, R., Landsverk, O. J. B., Johannessen, H., Phung, D., Nilsen, H. R., Sætre, F., Jahnsen, J., Horneland, R., Yaqub, S., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.02.030 · Cited by 9
Eysteinsdóttir, J. H., Freysdóttir, J., Skaftadóttir, I., Helgason, H., Haraldsson, Á., & Ogmundsdottir, H. M. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02203.x · Cited by 6
Ingram, W. A., Kordasti, S. Y., Chan, L., Barber, L. D., Tye, G. J., Hardwick, N. R., Mufti, G. J., & Farzaneh, F. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0679-6 · Cited by 6
Tumor Infiltrating Regulatory T Cells: Tractable Targets for Immunotherapy
Khan, A. R., Dovedi, S. J., Wilkinson, R. W., & Pritchard, D. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.508854 · Cited by 8
“In contrast to experiments in the mouse, the expression of Foxp3 alone does not confer a regulatory phenotype in man [23] as Foxp3 is also expressed transiently on activated T cells that do not exhibit regulatory function [24].”
ResultActivation of aryl hydrocarbon receptor prolongs survival of fully mismatched cardiac allografts
Cai, L., Yu, D.-W., Gao, Y., Yang, C., Zhou, H., & Chen, Z. K. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1097-8 · Cited by 7
Igney, F. H., Ebenhoch, R., Schiele, F., & Nar, H. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200072 · Cited by 5
“42).”
Protschka, M., Placido, D. D., Moore, P. F., Büttner, M., Alber, G., & Eschke, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1400550 · Cited by 9
“Whereas FoxP3 is a distinct marker of murine regulatory CD4 + T cells, in humans, activated non-regulatory CD4 + T cells were shown to also express FoxP3 albeit transiently, and at lower levels than human regulatory CD4 + T cells (41, 42).”
BackgroundLaytragoon‐Lewin, N., Jönson, F., Lundgren, J., Rutqvist, L. E., Wikby, A., Löfgren, S., & Lewin, F. (2014) · Medical Oncology · doi:10.1007/s12032-014-0290-3 · Cited by 5
Jursik, C., Michaela, P., Grillari‐Voglauer, R., Drbal, K., Fuertbauer, E., Jungfer, H., Albert, W. H. W., Steinhuber, E., Hemetsberger, T., Grillari, J., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2208 · Cited by 5
“In contrast to mice, human Foxp3 is not restricted to Tregs but rather a T-cell activation marker probably counterbalancing the stimulation process for maintaining homeostasis (70).”
BackgroundTsuda, M., Tone, Y., Ogawa, C., Nagaoka, Y., Katsumata, M., Necula, A. S., Howie, D., Masuda, E. S., Waldmann, H., & Tone, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00279 · Cited by 5
Taha, H. A., Hozayen, W. G., Okasha, A., Ahmed, A. E., Shata, M. A. A., Abdelnaem, E. A., & Maher, S. E. (2019) · Journal of Child Science · doi:10.1055/s-0039-1693158 · Cited by 6
Context-Dependent Effects Explain Divergent Prognostic Roles of Tregs in Cancer
Amblard, E., & Soumelis, V. (2022) · Cancers · doi:10.3390/cancers14122991 · Cited by 6
Asri, N., Rostami‐Nejad, M., Nikzamir, A., Aghamohammadi, E., Asadzadeh‐Aghdaei, H., & Zali, M. R. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07674-w · Cited by 4
“study, Foxp3 can also be transiently upregulated in human activated CD4+T cells that did not acquire suppressive capacity and were hyporesponsive to TCR stimulation [23].”
BackgroundGhazal, K., Moralès, O., Barjon, C., Dahlqvist, G., Aoudjehane, L., Ouaguia, L., Delhem, N., & Conti, F. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2018.10.005 · Cited by 5
Merlo, A. C., Tagliabue, E., Ménard, S., & Balsari, A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.01.006 · Cited by 5
Simoni, O. D., Santo, L. D., Scarpa, M., Munari, G., Spolverato, Y. C., Scapinello, A., Lonardi, S., Soldà, C., Bergamo, F., Fantin, A., et al. (2023) · Current Oncology · doi:10.3390/curroncol30060417 · Cited by 5
“, found that FOXP3 was significantly represented in poorly differentiated tumors [45].”
BackgroundBei, K. F., Moshkelgosha, S., Liu, B. J., & Juvet, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1291649 · Cited by 4
“T cells have also shown transient expression of FOXP3 without suppressive capabilities (57) as well FOXP3 has also been described in certain cancers (58, 59).”
BackgroundVerma, N. D., Al-Atiyah, R., Rakesh, P., Lam, A. D., Chiu, C., Tran, G. T., Hall, B. M., & Hodgkinson, S. J. (2025) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.22241 · Cited by 4
“Foxp3 is transiently expressed by human activated non-regulatory CD4 + T cells (Santegoets et al., 2015; Wang et al., 2007).”
Effects of CRISPR-Cas9-mediated FOXP3 knockout on CAR T cell potency
Peter, L., Farrera-Sal, M., Yaman, F. A., Dempewolf, N. H., Picht, S., Schulenberg, S., Kath, J., Hamm, F., Heinrich, F., Wagner, D. L., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101570 · Cited by 5
“3,4 9 While FOXP3 is constitutively expressed in Tregs, human conventional Teff can transiently upregulate FOXP3 upon activation, 10–14 suggesting it may act as a negative regulator of Teff function.”
Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls
Mirallas, O., Pretelli, G., Pena, M. B., Jiménez-Labaig, P., Hernando-Calvo, A., Tan, H. N., Selvadurai, P. N., de Lara, P. T., Vieito, M., Martín-Liberal, J., et al. (2026) · Annals of Oncology · doi:10.1016/j.annonc.2026.04.015 · Cited by 6
Pancreatic carcinoma development: new etiological and pathogenetic evidence
Fiorino, S., Reggiani, M. L. B., Pontoriero, L., Gallo, C. G., Chili, E., Masetti, M., Zanini, N., Grondona, A., Silvestri, T., Deleonardi, G., et al. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2013.242 · Cited by 4
Granzyme B May Act as an Effector Molecule to Control the Inflammatory Process in COPD
Kim, W. D., & Sin, D. D. (2024) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2023.2299104 · Cited by 5
“Therefore, the use of FoxP3 as a specific indicator of human nTreg cells has been increasingly questioned [53].”
Forkhead Box Protein P3 in the Immune System
Sato, Y. (2025) · Allergies · doi:10.3390/allergies5010006 · Cited by 4
“In contrast to murine T cells, human T cells express FOXP3 upon TCR stimulation [16,17].”
Soldevila, B., Alonso, N., Martínez-Arconada, M. J., Granada, M. L., Baía, D., Vallejos, V., Fraile, M., Morillas, R. M., Planas, R., Pujol‐Borrell, R., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04112.x · Cited by 4
Walldén, J. (2008) · Journal of Inflammation Research · doi:10.2147/jir.s3547 · Cited by 4
“Since Foxp3 up-regulation is associated with T cell activation in humans (Wang et al 2007), the decrease of Foxp3 expression from diagnosis toward 12 months after diagnosis could be a result of fading autoimmune attack with fi nal loss of β -cells.”
Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells
Tanimine, N., Burrell, B. E., Deng, K., Rickert, C. G., Lee, K. M., Feeney, N. J., Pardo, J., LeGuern, C., & Markmann, J. F. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.112987 · Cited by 5
Li, D., Chen, L., Miao, S.-Y., Zhou, M., Wu, J., Sun, S., Liu, L., Qi, C., & Xiong, X. (2022) · International Journal of COPD · doi:10.2147/copd.s371801 · Cited by 4
“However, it should be noted that FOXP3 induction relies on TCR signaling, which can be transiently induced when CD4CD25 T cells are activated under TCR stimulation.(41,42) We have also shown dynamic changes in CD25 and FOXP3 in peripheral CD4 T cells of patients with COPD, whose expression levels are influenced by the…”
BackgroundEnvironmental sensing and regulation of gene expression in CD4+ T cell subsets
Piccirillo, C. A. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.006 · Cited by 4
“In humans, FOXP3 upregulation on its own is insufficient to drive Treg development since FOXP3 is transiently expressed in normal, TCR-activated, effector T (Teff) cells without acquiring any regulatory function [18,19].”
BackgroundTREG cell control of autoimmune inflammation: a matter of timing?
Schulze‐Koops, H., & Skapenko, A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.155 · Cited by 4
“First, the phenotypic characterization of human T REG cells is difficult since reliable surface markers for T REG cells do not exist and the transcription factor characteristic of T REG cells, FOXP3, is also transiently expressed by activated human effector T cells”
BackgroundNew Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Angin, M., King, M., & Addo, M. M. (2013) · Journal of Visualized Experiments · doi:10.3791/50244 · Cited by 4
T-Regulatory Cells in Lymph Nodes
Arce, J., Levin, M., Xie, Q., Albanese, J. M., & Ratech, H. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpar39bfwnhwro · Cited by 4
de Wolf, A. C. M. T., Herberts, C. A., & Hoefnagel, M. H. N. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00091 · Cited by 4
Duggleby, R. C., Tsang, H. P., Strange, K. E., McWhinnie, A., Lamikanra, A., Roberts, D. J., Hernandez, D., Madrigal, J. A., & Danby, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240190 · Cited by 5
“However, this phenotype has some overlap with activated T cells, which may transiently express FOXP3 [2].”
BackgroundRafiqi, S. I., Aldasouqi, A., Paparodis, R. D., Dewan, S., Farooqi, A., Faisal, S., Nemat, Y., Salim, N., Qureshi, S., Mahmood, A., et al. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s504555 · Cited by 4
Hipp, H., Tondello, C., Gmehling, H., Scholz, L. K., Stavridou, A., Becker, M., Bührer, A.-M., Hintermann, E., Dirschl, S. M., Johannsmann, T. M., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102218 · Cited by 3
“Activated T cells show a transient upregulation of FOXP3 [28].”
Recent Development in Celiac Disease: Pathophysiology, Animal Models and Treatments
PATEL, V. G., Joharapurkar, A. A., & Jain, M. R. (2025) · Drug Development Research · doi:10.1002/ddr.70149 · Cited by 3
“T cells in LP lacks proliferation marker Ki67 in active form of CD. Additionally, these cells also express CD25 and Foxp3 (J Wang et al. 2007).”
Liu, C., He, S., Zhang, J., Zhu, J., Rao, J., Wang, K., Fan, Y., & Sun, Y. (2025) · Clinical & Experimental Allergy · doi:10.1111/cea.70158 · Cited by 3
Shafiei, M., Ardalan, N., Letafati, A., Nia, M. M. K., Bahavar, A., Shahnavaz, V., & Mozhgani, S. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2575368 · Cited by 4
“In addition, T cell activation transiently upregulates FoxP3 and CD25 expression [24,25].”
Liapopoulos, D., Sarantis, P., Zogas, G., Trifylli, E.-M., Bousou, T.-E., Kamitaki, K., Anastasiou, I. A., Kokkali, S., Mavromatis, S., Koustas, E., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104630 · Cited by 5
Kozela, E., & Juknat, A. (2016) · Immunome Research · doi:10.4172/1745-7580.10000108 · Cited by 2
“This is in agreement with a previous observation reporting that moderately increased FoxP3 activity transiently accompanies the activation of pathogenic T cells [46,47] while the classic regulatory T cell phenotypes are usually characterized by stable high levels of FoxP3 [48].”
ResultMetzker, M., Shipkova, M., von Ahsen, N., Andag, R., Abe, M., Canzler, O., Klett, C., Leicht, S., Olbricht, C. J., & Wieland, E. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.05.019 · Cited by 3
Dudina, G. A., Дмитриевна, Д. А., Litvina, M. M., Mitin, A. N., Mitina, T. A., & Polyakov, S. A. (2018) · Advances in Hematology · doi:10.1155/2018/8487403 · Cited by 3
You, Me and Foxp3: Immune Regulation for Two
Tsun, A., Li, Y. Y., & Li, B. (2011) · Immunotherapy · doi:10.2217/imt.11.118 · Cited by 3
Current reviews of allergy and clinical immunology
Leung, D. Y. M., Ledford, D. K., Bacchetta, R., Gambineri, E., & Roncarolo, M. (2007) · Cited by 3
Czaja, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00004-7 · Cited by 3
Umhoefer, J. M., Arce, M. M., Whalen, S., Dajani, R., Goudy, L., Kasinathan, S., Belk, J. A., Zhang, W., Zhou, R., Subramanya, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.30.610436 · Cited by 3
“While human Tregs constitutively express FOXP3 like murine Tregs, human CD4+CD25-conventional T cells (Tconvs) also transiently express FOXP3 upon cellular activation 13–15 .”
Divergent roles of macrophage subsets, FoxP3, and IL-17A in HSV-1–induced CNS pathology
Jaggi, U., Hirose, S., Wang, S., & Ghiasi, H. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013696 · Cited by 2
“Previously, it was shown that higher expression of FoxP3 in Treg cells is dependent on IL-2 [39,40].”
Immunopathology of the Outer Retina: Crosstalk With the Immune System
Wildner, G., Gehrke, M., & Strauß, O. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.12.032 · Cited by 2
Nirmala, S. S., Hu, Y., Floegel, F., Cruz, H., Morgenstern, J., Platz, A., Vollroth, M., & Fuchs, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1697723 · Cited by 2
A stage-based framework to interpret regulatory T cell biology after heart transplantation
Wang, Y., Ni, M., Zheng, A., Peng, Y., Liu, J., Xiong, Q., Wang, X., Savković, V., & Kang, S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1777360 · Cited by 2
Zarrinrad, G., Burkhardt, L.-M., Beltran-Mestres, C., Romero‐Suárez, S., Wagner, D. L., Schlickeiser, S., Stein, M., Wendering, D. J., de la Cebosa, I. J. C. D., Ehlen, L., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201735 · Cited by 2
“19,45,46 The TSDR methylation levels were similar in Treg WT and FKBP12 KO -Treg and no significantly different demethylated positions were shown, while Tcon showed increased methylation, thus confirming Treg identity and stability according to published scientific guidelines.”
Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities
Xie, J., Hamdy, H., & Elkord, E. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.03.007 · Cited by 2
Impact of in vitro HIV infection on human thymic regulatory T cell differentiation
Swaminathan, S., Scorza, T., Yero, A., Farnós, O., Schinkel, S. C. B., Angel, J. B., & Jenabian, M.-A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1217801 · Cited by 2
Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer
Shiomi, K., Ichinoe, M., Ushiwata, A., Eshima, K., Nagashio, R., Hayashi, S., Sonoda, D., Kondo, Y., Maruyama, R., Mikubo, M., et al. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03392-w · Cited by 2
“In addition, several papers have also shown that conventional CD4 + T cells can transiently express Foxp3 upon stimulation [34, 35].”
BackgroundHalaçlı, S. O., Inan, D., Esenboğa, S., Bildik, H. N., Bolat, A. B., Tezcan, İ., & Cağdaş, D. N. (2025) · Diagnostics · doi:10.3390/diagnostics15151879 · Cited by 3
“Expression of FOXP3 is considered a key transcription factor in the development and sustainability of the Tregs, even though some sub-populations of Tregs with suppressive effects do not express it [11–17].”
IPEX Syndrome: Clinical Profile, Biological Features, and Current Treatment
Bacchetta, R., Passerini, L., & Roncarolo, M. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_8 · Cited by 2
Yamawaki, K., Inuo, C., Nomura, T., Tanaka, K., Nakajima, Y., Kondo, Y., Yoshikawa, T., Urisu, A., & Tsuge, I. (2015) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.09.020 · Cited by 2
Immunoregulation in celiac disease
Mazzarella, G., & Aufiero, V. R. (2016) · Gastroenterology Hepatology and Endoscopy · doi:10.15761/ghe.1000103 · Cited by 2
“Infact, recently it has been shown that expression of Foxp3 does not exclusively occur in CD4+ CD25+ Treg cells, as in humans it can also be transiently induced in activated CD4+ CD25− T effector cells, which do not express Foxp3 in the resting state [51,52].”
BackgroundCongenital Immune Dysregulation Disorders
Fleisher, T. A., Oliveira, J. B., & Torgerson, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00013-6 · Cited by 2
Autorreactividad y autoinmunidad
Martín, D. D., Rodríguez, H. B., Cantera, M., & Zamarrón, L. M. (2017) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.12.011 · Cited by 3
Studies of Immune Regulation in Type 1 Diabetes
Honkanen, J. K. (2010) · Työväentutkimus Vuosikirja · Cited by 2
Reply to: “T regulatory cell number and function: The autoimmune traits in liver diseases”
Peiseler, M., Sebode, M., Schramm, C., & Herkel, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.014 · Cited by 2
A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEX
Ma, T., Song, X., Piccirillo, C. A., Deng, G., & Greene, M. I. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_2 · Cited by 1
Function and Therapeutic Intervention of Regulatory T Cells in Immune Regulation
Liu, Y., Hou, T., & Hao, H. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.104914 · Cited by 2
Reduced phosphorylated Foxp3 levels in Crimean Congo haemorrhagic fever
Gazi, U. (2022) · Tropical biomedicine · doi:10.47665/tb.39.4.016 · Cited by 1
“…et al., 2007; Dunham et al., 2008), Foxp3 protein expression alone was suggested not to be enough for generation of Treg cells (Allan et al., 2005), and was also detected in blood cells without any regulatory function (Gavin et al., 2006; Allan et al., 2007; Wang et al., 2007; Miyara et al., 2009).”
BackgroundFakihi, S. E., Allam, A. E., Tahoune, H., Kadi, C., Ibrahimi, A., Bourkadi, J. E., & Seghrouchni, F. (2025) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2025056518 · Cited by 2
Cardenas-Juarez, A., Uresti‐Rivera, E. E., Ochoa-González, F. D. L., Lira-Hernández, F. I., Lara-Ramirez, E. E., Morales, J. M. V., Rivas-Santiago, B. T., Portales‐Pérez, D. P., & García-Hernández, M. H. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2515411 · Cited by 1
“Activated human T cells can transiently express FOXP3 (Allan et al., 2007; Wang et al., 2007) and over expression of FOXP3 in T cells does not induce a suppressive FOXP3 + Treg cells phenotype (Allan et al., 2005; Tran et al., 2007).”
Retnakumar, S. V., Singh, S. C., Bonam, S. R., Chauvin, C., Mathew, M. J., Nielsen, I. B., Boyle, C., Hilgers, L., Søgaard, M. M., Platenburg, P. P., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1787181 · Cited by 2
“However, FoxP3 expression in human CD4 + T cells at early stages of activation can also re fl ect transient activation of conventional T cells rather than stable regulatory T cells (58), and functional suppressive activity of the FoxP3 + CD4 + T cells population was not assessed in this study.”
Zhang, Y., Zhu, Y., Liu, Z., Li, H., Zhong, B., Cui, X., Kong, Y., & Lu, H. J. (2026) · Cancer Drug Resistance · doi:10.20517/cdr.2026.27 · Cited by 3
Chen, Y., Shi, Y., & You, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02910-2 · Cited by 2
Power to the Tregs in transplantation tolerance in LATAM: From the basics to the bedside
Pino‐Lagos, K., & Soldevila, G. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102066 · Cited by 1
Vitamin D and Regulatory T Cells
Urry, Z., Dimeloe, S., & Hawrylowicz, C. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-888-7_5 · Cited by 1
Serafini, P., & Weed, D. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8809-5_13 · Cited by 1
Westin, J., Hellstrand, K., Dhillon, A. P., Lagging, M., & for the DITTO-HCV Study Group (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01277.x · Cited by 1
Nakajima, A., Murakami, R., & Hori, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2647-4_7 · Cited by 1
Analysis of FOXP3 DNA Methylation Patterns to Identify Functional FOXP3+ T-Cell Subpopulations
Minskaia, E., & de Lacerda, J. F. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2647-4_9 · Cited by 1
Lai, C. L., Santner‐Nanan, B., Maltese, P. J., Ong, C. K. S., Palmer, D. J., Campbell, D. E., Makrides, M., Gold, M., Nanan, R. K. H., Prescott, S. L., et al. (2024) · Allergy · doi:10.1111/all.16310 · Cited by 1
“2,19 Whilst there were no differences in IL- 4-expressing Th2 cells, we cannot exclude an expansion of smaller subsets of Th2 cells such as pathogenic Th2A cells, 3 or Tfh13 cells, 20 which were not examined in this study.”
Immunogenic Switch of RPE Cells
Sekulic, A., Wildner, G., Skerka, C., & Strauß, O. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-76550-6_61 · Cited by 1
Foxp3+ and CD4CD25+ T cells and its Clinical Relation to Type 1 Diabetes
Albrra, A. Y., Salman, W., & Omran, M. A. (2015) · Journals & Books Hosting (International Knowledge Sharing Platform) · Cited by 1
Regulatory T Cells: Their Role, Mechanism of Action, and Impact on Cancer
Cillo, A. R., & Vignali, D. A. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_6 · Cited by 1
Hassuna, N. A., Mansour, M., Ahmed, T. I., Hassan, E. A., Hefzy, M. M., El-Ghani, W. M. A. A., & Hefzy, E. M. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1674324 · Cited by 1
“that FoxP3 is also expressed after CD4 T cells activation (Wang et al. 2007).”
BackgroundProspects for studying of FOXP3 and its isoforms expression in allergic diseases
Smirnov, D. S., Kurbacheva, O. M., Polner, S. A., & Pavlova, K. S. (2017) · Russian Journal of Allergy · doi:10.36691/rja320 · Cited by 1
Immunological profile and aspects of immunotherapy in type 1 diabetes
Hjorth, M. (2010) · DiVA (Linkoping University) · Cited by 1
FoxP3 mRNA splice forms in arthritis patients
Ryder, L. R. (2011) · Cited by 1
Elucidating the role of regulatory T cells in colorectal cancer progression
Besneux, M. (2015) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 2
Samson, M., Janikashvili, N., Martin, L., Audia, S., & Bonnotte, B. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37863 · Cited by 1
Chauhan, S. K., Bartolomé-Casado, R., Landsverk, O. J. B., Johannessen, H., Phung, D., Sætre, F., Jahnsen, J., Horneland, R., Yaqub, S., Aandahl, E. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.12.941369 · Cited by 1
Depletion und Suppression humaner HLA-alloreaktiver T-Zellen durch CD95L-exprimierende Zellen
Bauer, S., & Friedrich, W. (2009)
PATOFIZIOLOŠKI MEHANIZMI U NASTANKU I LIJEČENJU ALERGIJSKIH BOLESTI
Pevec, B., Pevec, M. R., Marković, A. S., & Batišta, I. (2011) · Acta medica Croatica · Cited by 1
Eghtesad, S. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.